Niraparib 50 mg / abiraterone acetate 500 mg Oral Tablet
RxNorm 2645244
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2645244 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: niraparib 50 mg / abiraterone acetate 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Abiraterone acetate 500 mg / niraparib 50 mg Oral Tablet
(Atom ID: 12828128)
SYPrescribable
Synonym (SY):
Abiraterone acetate 500 mg / niraparib 50 mg (equivalent to 76.9 mg niraparib tosylate) Oral Tablet
(Atom ID: 12828137)
PSNPrescribable
Prescribable Name (PSN):
Niraparib 50 mg / abiraterone acetate 500 mg Oral Tablet
(Atom ID: 12828139)
Patient Education
Niraparib and Abiraterone
Niraparib and abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has already been treated with other medications and has spread to other parts of the body. Niraparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.
[Learn More]
* Please review the disclaimer below.